Physician profile
Alan P Aboaf
NPI 1003866393
$3,850.54
in general payments reported to CMS, 2019-2025
43 companies · $970 in 2025
The $970 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $76.18 · 2021: $279 · 2022: $569 · 2023: $871 · 2024: $764 · 2025: $970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,599 · Education: $5.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,599.33 |
| Education | $5.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $482.97 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $416.63 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Philips North America LLC | $336.73 | 2019-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Ck4) Mcot |
| Novo Nordisk INC | $312.01 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $206.34 | 2020-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Exact Sciences Corporation | $195.97 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $177.27 | 2021-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $109.00 | 2021-2025 | Mounjaro, Zepbound |
| Seqirus USA INC | $99.94 | 2023-2025 | Fluad, Flucelvax, Fluad Quadrivalent |
| Amgen INC. | $98.61 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $94.36 | 2024-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $92.58 | 2022-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Edwards Lifesciences Corporation | $92.09 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Teva Pharmaceuticals USA, INC. | $91.17 | 2019-2023 | Austedo |
| Dexcom, INC. | $80.17 | 2023-2025 | Dexcom G6 Transmitter |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Aboaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.